Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller
« Previous
123456789101112
Next »

Minding Your P's and Q's

As offshore savings decline, pharmaceutical companies still have a lot of work to do to reduce costs.
Oct 2, 2008
By: Jim Miller

As offshore savings decline, pharmaceutical companies still have a lot of work to do to reduce costs.

Clinical Outsourcing Steams Ahead

CMC service providers are doing well, but clinical and preclinical CROs are doing even better.
Sep 3, 2008
By: Jim Miller

CMC service providers are doing well, but clinical and preclinical CROs are doing even better.

Big Deals

Summer deals struck by Novartis and Lilly point to an evolution in contract services.
Sep 2, 2008
By: Jim Miller

Summer deals struck by Novartis and Lilly point to an evolution in contract services.

Clinical Outsourcing Steams Ahead

CMC service providers are doing well, but clinical and preclinical CROs are doing even better.
Aug 2, 2008
By: Jim Miller

CMC service providers are doing well, but clinical and preclinical CROs are doing even better.

Industry Outlook: Mixed Signals Lead to a New Outsourcing Equation

Survey results indicate a healthy market, but increasing competition.
Aug 1, 2008
By: Jim Miller

Survey results indicate a healthy market, but increasing competition.

Toward a New Model for Contract Manufacturing

Global manufacturing excellence will be a game changer for CMOs that can achieve it.
Jul 9, 2008
By: Jim Miller

Global manufacturing excellence will be a game changer for CMOs that can achieve it.

CMOs are Planning for the Last War

CMO business models are out of touch with current pharma industry realities. It's time for new thinking.
Jun 4, 2008
By: Jim Miller

CMO business models are out of touch with current pharma industry realities. It's time for new thinking.

Toward a New Model for Contract Manufacturing

Global manufacturing excellence will be a game changer for CMOs that can achieve it.
Jun 2, 2008
By: Jim Miller

Global manufacturing excellence will be a game changer for CMOs that can achieve it.

Weak Link in the Pharmaceutical Supply Chain

The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.
May 9, 2008
By: Jim Miller

The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here